Aging with HIV: Global report highlights the need to prepare health systems
The Lancet HIV Commission on Aging's 2026 report highlights how profoundly the global HIV epidemic is changing.
Aug 24, 2026
0
4
The Lancet HIV Commission on Aging's 2026 report highlights how profoundly the global HIV epidemic is changing.
Aug 24, 2026
0
4
Every year, more than 120,000 newborns worldwide contract HIV, creating a global health burden that requires lifelong treatment for millions of people—assuming they have access and can afford it. New research led by Oregon ...
Aug 10, 2026
0
128
As more Americans with HIV live into older age, Medicare spending on their care is projected to rise dramatically from $10.9 billion in 2026 to $27.3 billion in 2035, with HIV medications accounting for nearly two-thirds ...
Aug 7, 2026
0
4
Hundreds of people in England who were unknowingly living with HIV are receiving a diagnosis and starting life-saving antiretroviral treatment, thanks to a pioneering NHS testing initiative rolled out in hospital emergency ...
Jun 26, 2026
0
10
In the ongoing effort to find new therapeutics for infants born infected with the human immunodeficiency virus, an international team of investigators has discovered that babies can tolerate treatment with anti-HIV antibodies.
Growing up witnessing the devastating effects of HIV in her family and community in South Africa pushed Olwam Plaatjie to start using preventive HIV medications three years ago.
Jun 9, 2026
0
4
Antiretroviral drugs for HIV infection have enabled most people living with the virus to live long and healthy lives. However, a small portion of people experience detectable—and worrisome—traces of the virus that causes ...
Jun 8, 2026
0
23
For many people living with HIV, today's treatments can suppress the virus and dramatically improve health. But even when HIV is controlled, damage to the gut caused by the disease can persist, fueling chronic inflammation ...
May 25, 2026
0
19
Fourteen years ago, NTNU surgeon Håkon Bolkan made a prediction about a training program he and his colleagues had newly begun to expand access to surgery in the West African country of Sierra Leone.
May 14, 2026
0
4
The U.S. Food and Drug Administration has approved Merck's Idvynso (doravirine/islatravir), a new, once-daily, two-drug single tablet for the treatment of HIV-1 infection in adults to replace the current antiretroviral regimen ...
May 1, 2026
0
27